Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics

被引:19
作者
Lu, Hao [1 ]
Iuliano, James N. [2 ]
Tonge, Peter J. [2 ,3 ]
机构
[1] EMD Serono Res & Dev Inst Inc, Billerica, MA 01821 USA
[2] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Sch Med, Dept Radiol, Stony Brook, NY 11794 USA
基金
美国国家卫生研究院;
关键词
SLOW-ONSET INHIBITION; TRANSITION-STATE ANALOGS; P38 MAP KINASE; LEAD OPTIMIZATION; BINDING-KINETICS; COVALENT DRUGS; R-SPINE; DISCOVERY; MECHANISM; RECEPTOR;
D O I
10.1016/j.cbpa.2018.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Time-dependent target occupancy is a function of both the thermodynamics and kinetics of drug-target interactions. However, while the optimization of thermodynamic affinity through approaches such as structure-based drug design is now relatively straight forward, less is understood about the molecular interactions that control the kinetics of drug complex formation and breakdown since this depends on both the ground and transition state energies on the binding reaction coordinate. In this opinion we highlight several recent examples that shed light on current approaches that are elucidating the factors that control the life-time of the drug-target complex.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 60 条
  • [1] Protein conformational flexibility modulates kinetics and thermodynamics of drug binding
    Amaral, M.
    Kokh, D. B.
    Bomke, J.
    Wegener, A.
    Buchstaller, H. P.
    Eggenweiler, H. M.
    Matias, P.
    Sirrenberg, C.
    Wade, R. C.
    Frech, M.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [2] Phase II failures: 2008-2010
    Arrowsmith, John
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 1 - 1
  • [3] TRIAL WATCH Phase III and submission failures: 2007-2010
    Arrowsmith, John
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (02) : 1 - 1
  • [4] Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9
    Ayaz, Pelin
    Andres, Dorothee
    Kwiatkowski, Dennis A.
    Kolbe, Carl-Christian
    Lienau, Philip
    Siemeister, Gerhard
    Luecking, Ulrich
    Stegmann, Christian M.
    [J]. ACS CHEMICAL BIOLOGY, 2016, 11 (06) : 1710 - 1719
  • [5] Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile
    Barf, Tjeerd
    Covey, Todd
    Izumi, Raquel
    van de Kar, Bas
    Gulrajani, Michael
    van Lith, Bart
    van Hoek, Maaike
    de Zwart, Edwin
    Mittag, Diana
    Demont, Dennis
    Verkaik, Saskia
    Krantz, Fanny
    Pearson, Paul G.
    Ulrich, Roger
    Kaptein, Allard
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 363 (02) : 240 - 252
  • [6] Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
    Basavapathruni, Aravind
    Jin, Lei
    Daigle, Scott R.
    Majer, Christina R. A.
    Therkelsen, Carly A.
    Wigle, Tim J.
    Kuntz, Kevin W.
    Chesworth, Richard
    Pollock, Roy M.
    Scott, Margaret P.
    Moyer, Mikel P.
    Richon, Victoria M.
    Copeland, Robert A.
    Olhava, Edward J.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (06) : 971 - 980
  • [7] Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/nchembio.1817, 10.1038/NCHEMBIO.1817]
  • [8] Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus Fabl Enzyme-Product Complex
    Chang, Andrew
    Schiebel, Johannes
    Yu, Weixuan
    Bommineni, Gopal R.
    Pan, Pan
    Baxter, Michael V.
    Khanna, Avinash
    Sotriffer, Christoph A.
    Kisker, Caroline
    Tonge, Peter J.
    [J]. BIOCHEMISTRY, 2013, 52 (24) : 4217 - 4228
  • [9] Opinion - Drug-target residence time and its implications for lead optimization
    Copeland, Robert A.
    Pompliano, David L.
    Meek, Thomas D.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) : 730 - 739
  • [10] Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin
    Cramer, Jonathan
    Krimmer, Stefan G.
    Fridh, Veronica
    Wulsdorf, Tobias
    Karlsson, Robert
    Heine, Andreas
    Klebe, Gerhard
    [J]. ACS CHEMICAL BIOLOGY, 2017, 12 (01) : 225 - 233